Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5100 | 1672 | 42.6 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
33 | 3 | JOURNAL OF BACTERIOLOGY//MICROBIOLOGY//MOLECULAR MICROBIOLOGY | 107033 |
959 | 2 | BACTERIOPHAGE//PHAGE THERAPY//ENDOLYSIN | 10780 |
5100 | 1 | PHAGE THERAPY//BACTERIOPHAGE//BACTERIOPHAGE THERAPY | 1672 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PHAGE THERAPY | authKW | 2438081 | 11% | 76% | 176 |
2 | BACTERIOPHAGE | authKW | 2123817 | 30% | 23% | 502 |
3 | BACTERIOPHAGE THERAPY | authKW | 490164 | 2% | 73% | 37 |
4 | PHAGE COCKTAIL | authKW | 256794 | 1% | 94% | 15 |
5 | PHAGE THER Y UNIT | address | 223694 | 1% | 88% | 14 |
6 | BACTERIOPHAGES | address | 187825 | 1% | 86% | 12 |
7 | MYOVIRIDAE | authKW | 183004 | 1% | 48% | 21 |
8 | PHAGE | authKW | 172041 | 4% | 14% | 69 |
9 | LYTIC PHAGE | authKW | 150785 | 1% | 52% | 16 |
10 | GENE TECHNOL | address | 111105 | 4% | 9% | 67 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Microbiology | 21003 | 47% | 0% | 781 |
2 | Virology | 7197 | 16% | 0% | 269 |
3 | Biotechnology & Applied Microbiology | 5189 | 24% | 0% | 407 |
4 | Food Science & Technology | 716 | 9% | 0% | 143 |
5 | Agriculture, Dairy & Animal Science | 177 | 3% | 0% | 48 |
6 | Infectious Diseases | 148 | 4% | 0% | 60 |
7 | Fisheries | 90 | 2% | 0% | 30 |
8 | Veterinary Sciences | 74 | 3% | 0% | 58 |
9 | Genetics & Heredity | 70 | 4% | 0% | 70 |
10 | Immunology | 60 | 5% | 0% | 81 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHAGE THER Y UNIT | 223694 | 1% | 88% | 14 |
2 | BACTERIOPHAGE | 219727 | 1% | 63% | 19 |
3 | BACTERIOPHAGES | 187825 | 1% | 86% | 12 |
4 | GENE TECHNOL | 111105 | 4% | 9% | 67 |
5 | MOL BIOL GENE EXTREMOPHILES UNIT | 83392 | 1% | 35% | 13 |
6 | FELIX DHERELLE REFERENCE BACTERIAL VIRUSES | 82994 | 1% | 45% | 10 |
7 | FOODBORNE ZOONOSES | 82916 | 3% | 10% | 47 |
8 | MICROBIOL IMMUNOL INFECTIOL | 73947 | 1% | 45% | 9 |
9 | GENET BACTERIOPHAGES | 73044 | 0% | 100% | 4 |
10 | MOL CELLULAR TECHNOL MCT | 58434 | 0% | 80% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | APPLIED AND ENVIRONMENTAL MICROBIOLOGY | 6759 | 6% | 0% | 106 |
2 | ARCHIVES OF VIROLOGY | 6406 | 3% | 1% | 55 |
3 | FRONTIERS IN MICROBIOLOGY | 5795 | 3% | 1% | 42 |
4 | VIRUSES-BASEL | 4887 | 1% | 1% | 21 |
5 | VIROLOGY JOURNAL | 4684 | 2% | 1% | 28 |
6 | RESEARCH IN MICROBIOLOGY | 3628 | 1% | 1% | 23 |
7 | JOURNAL OF APPLIED MICROBIOLOGY | 3007 | 2% | 1% | 33 |
8 | ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS | 2733 | 1% | 1% | 15 |
9 | FOODBORNE PATHOGENS AND DISEASE | 2404 | 1% | 1% | 14 |
10 | FEMS MICROBIOLOGY LETTERS | 2263 | 3% | 0% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHAGE THERAPY | 2438081 | 11% | 76% | 176 | Search PHAGE+THERAPY | Search PHAGE+THERAPY |
2 | BACTERIOPHAGE | 2123817 | 30% | 23% | 502 | Search BACTERIOPHAGE | Search BACTERIOPHAGE |
3 | BACTERIOPHAGE THERAPY | 490164 | 2% | 73% | 37 | Search BACTERIOPHAGE+THERAPY | Search BACTERIOPHAGE+THERAPY |
4 | PHAGE COCKTAIL | 256794 | 1% | 94% | 15 | Search PHAGE+COCKTAIL | Search PHAGE+COCKTAIL |
5 | MYOVIRIDAE | 183004 | 1% | 48% | 21 | Search MYOVIRIDAE | Search MYOVIRIDAE |
6 | PHAGE | 172041 | 4% | 14% | 69 | Search PHAGE | Search PHAGE |
7 | LYTIC PHAGE | 150785 | 1% | 52% | 16 | Search LYTIC+PHAGE | Search LYTIC+PHAGE |
8 | PODOVIRIDAE | 102245 | 1% | 40% | 14 | Search PODOVIRIDAE | Search PODOVIRIDAE |
9 | DHERELLE | 76086 | 0% | 83% | 5 | Search DHERELLE | Search DHERELLE |
10 | SIPHOVIRIDAE | 75377 | 1% | 26% | 16 | Search SIPHOVIRIDAE | Search SIPHOVIRIDAE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WEBER-DABROWSKA, B , JONCZYK-MATYSIAK, E , ZACZEK, M , LOBOCKA, M , LUSIAK-SZELACHOWSKA, M , GORSKI, A , (2016) BACTERIOPHAGE PROCUREMENT FOR THERAPEUTIC PURPOSES.FRONTIERS IN MICROBIOLOGY. VOL. 7. ISSUE . P. - | 81 | 81% | 0 |
2 | ABEDON, ST , THOMAS-ABEDON, C , (2010) PHAGE THERAPY PHARMACOLOGY.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 11. ISSUE 1. P. 28 -47 | 82 | 67% | 35 |
3 | SARHAN, WA , AZZAZY, HME , (2015) PHAGE APPROVED IN FOOD, WHY NOT AS A THERAPEUTIC?.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 13. ISSUE 1. P. 91 -101 | 58 | 85% | 4 |
4 | O'FLAHERTY, S , ROSS, RP , COFFEY, A , (2009) BACTERIOPHAGE AND THEIR LYSINS FOR ELIMINATION OF INFECTIOUS BACTERIA.FEMS MICROBIOLOGY REVIEWS. VOL. 33. ISSUE 4. P. 801 -819 | 78 | 61% | 98 |
5 | CHAN, BK , ABEDON, ST , LOC-CARRILLO, C , (2013) PHAGE COCKTAILS AND THE FUTURE OF PHAGE THERAPY.FUTURE MICROBIOLOGY. VOL. 8. ISSUE 6. P. 769 -783 | 52 | 71% | 84 |
6 | CHAN, BK , ABEDON, ST , (2015) BACTERIOPHAGES AND THEIR ENZYMES IN BIOFILM CONTROL.CURRENT PHARMACEUTICAL DESIGN. VOL. 21. ISSUE 1. P. 85 -99 | 77 | 57% | 8 |
7 | BULL, JJ , GILL, JJ , (2014) THE HABITS OF HIGHLY EFFECTIVE PHAGES: POPULATION DYNAMICS AS A FRAMEWORK FOR IDENTIFYING THERAPEUTIC PHAGES.FRONTIERS IN MICROBIOLOGY. VOL. 5. ISSUE . P. - | 55 | 87% | 6 |
8 | WITTEBOLE, X , DE ROOCK, S , OPAL, SM , (2014) A HISTORICAL OVERVIEW OF BACTERIOPHAGE THERAPY AS AN ALTERNATIVE TO ANTIBIOTICS FOR THE TREATMENT OF BACTERIAL PATHOGENS.VIRULENCE. VOL. 5. ISSUE 1. P. 226-235 | 52 | 69% | 32 |
9 | VANDENHEUVEL, D , LAVIGNE, R , BRUSSOW, H , (2015) BACTERIOPHAGE THERAPY: ADVANCES IN FORMULATION STRATEGIES AND HUMAN CLINICAL TRIALS.ANNUAL REVIEW OF VIROLOGY, VOL 2. VOL. 2. ISSUE . P. 599 -618 | 54 | 67% | 10 |
10 | CHOUDHURY, TG , NAGARAJU, VT , PARHI, J , PARIA, A , GITA, S , (2017) ADVANCES IN BACTERIOPHAGE RESEARCH FOR BACTERIAL DISEASE CONTROL IN AQUACULTURE.REVIEWS IN FISHERIES SCIENCE & AQUACULTURE. VOL. 25. ISSUE 2. P. 113 -125 | 54 | 75% | 0 |
Classes with closest relation at Level 1 |